<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jnutbio.com/?rss=yes"><title>The Journal of Nutritional Biochemistry</title><description>The Journal of Nutritional Biochemistry RSS feed: Current Issue. Devoted to advancements in nutritional sciences, the  The Journal of Nutritional Biochemistry  presents experimental nutrition 
research as it relates to: biochemistry, neurochemistry, molecular biology, toxicology, physiology and pharmacology. Rigorous reviews 
by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted 
in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research communications, 
the  The Journal of Nutritional Biochemistry  also periodically publishes emerging issues, conference summaries, experimental 
methods, symposium reports, metabolic pathways, and short communications.</description><link>http://www.jnutbio.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2010 Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:issn>0955-2863</prism:issn><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:publicationDate>February 2010</prism:publicationDate><prism:copyright> © 2010 Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900254X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002174/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002362/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002453/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002465/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002490/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002532/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002556/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002568/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002659/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002660/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286308002696/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900254X/abstract?rss=yes"><title>Contents</title><link>http://www.jnutbio.com/article/PIIS095528630900254X/abstract?rss=yes</link><description></description><dc:title>Contents</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0955-2863(09)00254-X</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>i</prism:startingPage><prism:endingPage>i</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002174/abstract?rss=yes"><title>Mouse models for unraveling the importance of diet in colon cancer prevention</title><link>http://www.jnutbio.com/article/PIIS0955286309002174/abstract?rss=yes</link><description>Abstract: Diet and genetics are both considered important risk determinants for colorectal cancer, a leading cause of death worldwide. Several genetically engineered mouse models have been created, including the ApcMin mouse, to aid in the identification of key cancer related processes and to assist with the characterization of environmental factors, including the diet, which influence risk. Current research using these models provides evidence that several bioactive food components can inhibit genetically predisposed colorectal cancer, while others increase risk. Specifically, calorie restriction or increased exposure to n-3 fatty acids, sulforaphane, chafuroside, curcumin and dibenzoylmethane were reported protective. Total fat, calories and all-trans retinoic acid are associated with an increased risk. Unraveling the importance of specific dietary components in these models is complicated by the basal diet used, the quantity of test components provided and interactions among food components. Newer models are increasingly available to evaluate fundamental cellular processes, including DNA mismatch repair, immune function and inflammation as markers for colon cancer risk. Unfortunately, these models have been used infrequently to examine the influence of specific dietary components. The enhanced use of these models can shed mechanistic insights about the involvement of specific bioactive food and components and energy as determinants of colon cancer risk. However, the use of available mouse models to exactly represent processes important to human gastrointestinal cancers will remain a continued scientific challenge.</description><dc:title>Mouse models for unraveling the importance of diet in colon cancer prevention</dc:title><dc:creator>Alexandra E. Tammariello, John A. Milner</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.014</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Reviews: Current Topics</prism:section><prism:startingPage>77</prism:startingPage><prism:endingPage>88</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002362/abstract?rss=yes"><title>The effect of high-amylose cornstarch on lipid metabolism in OVX rats is affected by fructose feeding</title><link>http://www.jnutbio.com/article/PIIS0955286308002362/abstract?rss=yes</link><description>Abstract: We examined whether the effects of high-amylose cornstarch (HACS) on lipid metabolism in ovariectomized (OVX) rats were affected by high-fructose feeding. Sucrose (482 g/kg diet) was used as fructose source. OVX rats were fed one of the following four diets for 21 days: a sucrose-based or cornstarch-based cholesterol-free diet with or without HACS (150 g/kg diet). Body weight and food intake were increased by sucrose. Plasma total cholesterol and low-density lipoprotein cholesterol concentrations were increased by sucrose and decreased by HACS in cornstarch-fed rats, but not in sucrose-fed rats. Liver total lipids and concentrations of plasma and liver triacylglycerol (TAG) were increased by sucrose, whereas plasma TAG concentration was decreased by HACS, in sucrose-fed rats. However, liver cholesterol concentration was not affected by diet. The amount of cholesterol in small-intestinal contents was increased in sucrose-fed rats, but not in cornstarch-fed rats, but that of bile acids was not affected by diet. Fecal excretions of bile acids and neutral sterols were increased by HACS. The level of sterol-regulatory element-binding protein-1c mRNA was increased by sucrose and decreased by HACS in sucrose-fed rats, but not in cornstarch-fed rats. The level of farnesoid X receptor mRNA was decreased by sucrose and increased by HACS in cornstarch-fed rats, but not in sucrose-fed rats, as was the level of cholesterol 7α-hydroxylase mRNA. These results show that the effect of HACS on hyperlipidemia induced by ovarian hormone deficiency would be affected by the consumption of fructose-rich sweeteners such as sucrose and high-fructose syrup.</description><dc:title>The effect of high-amylose cornstarch on lipid metabolism in OVX rats is affected by fructose feeding</dc:title><dc:creator>Xiong Liu, Hiroshi Ogawa, Taro Kishida, Kiyoshi Ebihara</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.10.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-01-21</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>89</prism:startingPage><prism:endingPage>97</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002453/abstract?rss=yes"><title>A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level</title><link>http://www.jnutbio.com/article/PIIS0955286308002453/abstract?rss=yes</link><description>Abstract: The main aims of this study were to elucidate the effect of green tea catechins on Nudix-type motif 6 (NUDT6) suppression and to characterize NUDT6's biological activity. Our microarray data showed that the green tea component epicatechin-3-gallate suppressed NUDT6 expression, and this was confirmed by RT-PCR. Subsequently, the use of different catechins showed that the effect of epigallocatechin-3-gallate (EGCG) was stronger than that of other catechins. At the posttranscriptional level, EGCG decreased the RNA stability of NUDT6, indicating it as a potential mechanism of NUDT6 suppression. Further cloning of the 3′ untranslated region of human NUDT6 mRNA resulted in reduced luciferase activity by EGCG treatment. This effect was at least, in part, mediated by the extracellular-signal-regulated kinase and p38MAPK pathways. Finally, increased cell proliferation and cell growth in soft agar were observed in NUDT6-overexpressing cells. These findings provide a novel mechanism for the suppression of the proliferative gene NUDT6 by green tea catechins in human colorectal cancer.</description><dc:title>A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level</dc:title><dc:creator>Mugdha Sukhthankar, Chang K. Choi, Anthony English, Jong-Sik Kim, Seung Joon Baek</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.11.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-01-21</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>98</prism:startingPage><prism:endingPage>106</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002465/abstract?rss=yes"><title>Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice</title><link>http://www.jnutbio.com/article/PIIS0955286308002465/abstract?rss=yes</link><description>Abstract: Conjugated linoleic acid (CLA) modulates body composition, especially by reducing adipose tissue. However, despite the increasing knowledge about CLA's beneficial effects on obesity management, the mechanism of action is not yet fully understood. Furthermore, in some human studies fat loss is accompanied by impairment in insulin sensitivity, especially when using the trans-10,cis-12 isomer. The aim of this work was to study the effects of moderate doses of CLA on body fat deposition, cytokine profile and inflammatory markers in mice. Mice were orally treated with a mixture of CLA isomers, cis-9,trans-11 and trans-10,cis-12 (50:50), for 35 days with doses of CLA1 (0.15 g CLA/kg body weight) and CLA2 (0.5 g CLA/kg body weight). CLA had discrete effects on body weight but caused a clear reduction in fat mass (retroperitoneal and mesenteric as the most sensitive depots), although no other tissue weights were affected. Glucose and insulin were not altered by CLA treatment, and maintenance of glucose homeostasis was observed even under insulin overload. The study of gene expression (Emr1, MCP-1, IL-6, TNFα, PPARγ2 and iNOS) either in adipocytes and/or in the stromal vascular fraction indicated that CLA does not lead to the infiltration of macrophages in adipose tissue or to the induction of expression of pro-inflammatory cytokines. The use of a mixture of both isomers, as well as moderate doses of CLA, is able to induce a reduction of fat gain without an impairment of adipose tissue function while preserving insulin sensitivity.</description><dc:title>Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice</dc:title><dc:creator>Pilar Parra, Francisca Serra, Andreu Palou</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.10.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-02-06</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-02-06</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>107</prism:startingPage><prism:endingPage>115</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002490/abstract?rss=yes"><title>Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor α-induced adhesion molecule expression in human endothelial cells</title><link>http://www.jnutbio.com/article/PIIS0955286308002490/abstract?rss=yes</link><description>Abstract: Diabetes mellitus is associated with increased endothelial dysfunction and development of atherosclerotic vascular diseases. In contrast, an increased intake of dietary flavonoids is associated with a decreased risk of cardiovascular diseases. Here we demonstrate that high glucose (HG) and tumor necrosis factor α (TNFα) result in the expression of adhesion molecules and junctional molecules on endothelial cells (EC) within a short time. Simultaneously, we examined the regulatory effects of several dietary flavonoids. We demonstrated the short-term expression of adhesion molecules in a human EC line cultured with normal glucose (5.5 mM), HG (30 mM) and TNFα (10 ng/ml) by reverse transcription–polymerase chain reaction (RT-PCR), immunocytochemistry and adhesion assay. The expression of intercellular adhesion molecule-1 (ICAM1) and vascular cell adhesion molecule-1 (VCAM1) increased, but that of occludin decreased. Apigenin strongly inhibited the expression of VCAM1, IκB kinase (IKK) α and IKKɛ/IKKi, and suppressed the adhesion of U937 cells. From the structure and inhibitory activity of several dietary flavonoids, it was recognized that a double bond between apigenin and the third hydroxyl group was required for inhibition of gene expression. HG and TNFα induced the expression of cell adhesion molecules and reduced that of occludin in EC. These flavonoids modified the expression of cloudin 5 and occludin. These results demonstrated that apigenin inhibits HG- and TNFα-induced adhesion molecule expression and that flavonoids regulate the expression of junctional molecules in human EC. It is suggested that apigenin inhibited the expression of several genes through inhibition of IKKs.</description><dc:title>Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor α-induced adhesion molecule expression in human endothelial cells</dc:title><dc:creator>Kazuo Yamagata, Akinori Miyashita, Hiroshi Matsufuji, Makoto Chino</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.11.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-02-06</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-02-06</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>116</prism:startingPage><prism:endingPage>124</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002532/abstract?rss=yes"><title>Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system</title><link>http://www.jnutbio.com/article/PIIS0955286308002532/abstract?rss=yes</link><description>Abstract: The vascular effects of nitrolinoleate (LNO2), an endogenous product of linoleic acid (LA) nitration by nitric oxide-derived species and a potential nitrosating agent, were investigated on rat endothelial-leukocyte interactions. Confocal microscopy analysis demonstrated that LNO2 was capable to deliver free radical nitric oxide (·NO) into cells, 5 min after its administration to cultured cells, with a peak of liberation at 30 min. THP-1 monocytes incubated with LNO2 for 5 min presented nitrosation of CD40, leading to its inactivation. Other anti-inflammatory actions of LNO2 were observed in vivo by intravital microscopy assays. LNO2 decreased the number of adhered leukocytes in postcapillary venules of the mesentery network. In addition to this, LNO2 reduced mRNA and protein expression of β2-integrin in circulating leukocytes, as well as VCAM-1 in endothelial cells isolated from postcapillary venules, confirming its antiadhesive effects on both cell types. Moreover, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, a nitric oxide scavenger, partially abolished the inhibitory action of LNO2 on leukocyte-endothelium interaction, suggesting that the antiadhesion effects of LNO2 involve a dual role in leukocyte adhesion, acting as a nitric oxide donor as well as through nitric oxide-independent mechanisms. In conclusion, LNO2 inhibited adhesion molecules expression and promoted ·NO inactivation of the CD40–CD40L system, both important processes of the inflammatory response.</description><dc:title>Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system</dc:title><dc:creator>Luciane A. Faine, Danielle M.H. Cavalcanti, Martina Rudnicki, Simone Ferderbar, Sandra M.D. Macedo, Heraldo P. Souza, Sandra H.P. Farsky, Lisardo Boscá, Dulcineia Saes Parra Abdalla</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-02-06</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-02-06</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>125</prism:startingPage><prism:endingPage>132</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002556/abstract?rss=yes"><title>Lutein bioavailability from lutein ester-fortified fermented milk: in vivo and in vitro study</title><link>http://www.jnutbio.com/article/PIIS0955286308002556/abstract?rss=yes</link><description>Abstract: We assessed the bioavailability of lutein from lutein-fortified fermented milk using in vivo and in vitro approaches. Twenty-four volunteers were randomized to take lutein-fortified fermented milk at two levels of fortification. Single-dose bioavailability study (2×100 ml, ca. 8 or 16 mg of lutein) was performed using a three-point approach (baseline, 3.5 and 6.5 h). Multiple-dose study consisted of consuming one serving/day (ca. 4 or 8 mg/100 ml) for 14 days. Blood samples for biochemical, hematological and lutein analysis were drawn at baseline, Day 7 and Day 14. In vitro bioaccessibility was assessed by a static gastrointestinal digestion model. Lutein content, in vitro ester hydrolysis and micellarization, and lutein concentrations achieved in serum were analyzed by HPLC. In vivo, post-prandial response was higher using the high content fermented milk, but the percentage of absorption was not different according to the dose consumed. Net increments at Day 7 and Day 14 were significantly higher on consuming the high-dose milk as well. In vitro, lutein ester hydrolysis was incomplete regardless of the amount initially present. Free lutein released was higher using the high-dose fermented milk, but the percentage of hydrolysis was similar at both levels of fortification. In the micellar phase, the percentage of free and total lutein was not different according to the dose. Our results support the suitability of the fermented milk as a carrier of lutein esters and an in vivo dose-dependent effect upon regular consumption and suggest the usefulness of in vitro models to provide relevant information to predict in vivo responses.</description><dc:title>Lutein bioavailability from lutein ester-fortified fermented milk: in vivo and in vitro study</dc:title><dc:creator>Fernando Granado-Lorencio, Carmer Herrero-Barbudo, Begoña Olmedilla-Alonso, Inmaculada Blanco-Navarro, Belén Pérez-Sacristán</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-02-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-02-09</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>133</prism:startingPage><prism:endingPage>139</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002568/abstract?rss=yes"><title>Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells</title><link>http://www.jnutbio.com/article/PIIS0955286308002568/abstract?rss=yes</link><description>Abstract: Epigallocatechin gallate (EGCG) is a major type of green tea polyphenols and is known to have cancer prevention effect. MicroRNAs (miRNAs) are 19 to 25 nucleotides and are believed to be important in gene regulation. In the present study, the influence of EGCG on the expressions of miRNAs in human cancer cells was investigated as this has not yet been reported. By miRNA microarray analysis, EGCG treatment was found to modify the expressions of some of the miRNAs in human hepatocellular carcinoma HepG2 cells, 13 were up-regulated and 48 were down-regulated. miR-16 is one of the miRNAs up-regulated by EGCG and one of its target genes is confirmed to be the anti-apoptotic protein Bcl-2. EGCG treatment induced apoptosis and down-regulated Bcl-2 in HepG2 cells. Transfection with anti-miR-16 inhibitor suppressed miR-16 expression and counteracted the EGCG effects on Bcl-2 down-regulation and also induction of apoptosis in cells. Results from the present study confirm the role of miR-16 in mediating the apoptotic effect of EGCG and also support the importance of miRNAs in the regulation of the biological activity of EGCG.</description><dc:title>Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells</dc:title><dc:creator>Wing Pui Tsang, Tim Tak Kwok</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-03-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-03-09</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>140</prism:startingPage><prism:endingPage>146</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002659/abstract?rss=yes"><title>Yogurt protects against growth retardation in weanling rats fed diets high in phytic acid</title><link>http://www.jnutbio.com/article/PIIS0955286308002659/abstract?rss=yes</link><description>Abstract: The purpose of this study was to determine the effects of adding yogurt to animal diets that were high in phytic acid (PA) and adequate in zinc (38 μg Zn/g). The PA:Zn molar ratio was 60:1. Zinc status was determined by documenting growth and measuring the zinc concentration in bone (tibia) and plasma. For 25 days, six groups (n=6) of Sprague–Dawley weanling rats were fed one of six AIN-76 diets. Half of the diets contained PA. Four of the diets contained yogurt with either active or heat-treated (inactive) cultures added at 25% of the diet. The diets were as follows: (a) AIN, (b) AIN with active yogurt, (c) AIN and inactive yogurt, (d) AIN with PA, (e) AIN with PA plus active yogurt and (f) AIN with PA plus inactive yogurt. Body weight, weight gain and zinc concentration in bone and plasma were measured, and food efficiency ratio was calculated. Rats fed diets with PA and yogurt had normal growth compared to the control group. Growth retardation was evident in the group fed the diet with PA and no yogurt. This group had significantly lower body weight compared to all other groups (P&lt;.05). Rats fed diets with PA, with or without yogurt, had significantly lower zinc concentration in bone and plasma (P&lt;.05). Adding yogurt to diets high in PA resulted in normal growth in weanling rats; however, zinc concentration in bone and plasma was still suboptimal.</description><dc:title>Yogurt protects against growth retardation in weanling rats fed diets high in phytic acid</dc:title><dc:creator>Lisa M. Gaetke, Craig J. McClain, C. Jean Toleman, Mary A. Stuart</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-03-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-03-09</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>147</prism:startingPage><prism:endingPage>152</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002660/abstract?rss=yes"><title>Regulation of cellular glutathione peroxidase by different forms and concentrations of selenium in primary cultured bovine hepatocytes</title><link>http://www.jnutbio.com/article/PIIS0955286308002660/abstract?rss=yes</link><description>Abstract: The expression and activity of cellular glutathione peroxidase (GPx1) are regulated by selenium (Se). Generally speaking, organic forms of Se have less toxicity and greater bioavailability compared with inorganic forms. In this study, the effects of different forms and concentrations of Se on the regulation of mRNA level and activity of GPx1 in bovine hepatocytes were evaluated, and the optimal doses of different forms of Se that supported the full expression of GPx1 were determined. Primary cultured bovine hepatocyte monolayers derived from neonatal male Holstein calves (aged 1–2 days) were incubated for 24 h with 0 (control), 0.5, 1, 1.5, 2, 3, 4 or 5 μmol/L of Se from dl-selenomethionine (Se-Met), sodium selenite (Na2SeO3) or Kappa-selenocarrageenan (Se-Car). Compared with controls, a significantly lower level of release of lactic dehydrogenase (LDH) was observed at 0.5–5 μmol/L of Se-Met, 0.5–1 μmol/L of Na2SeO3 and 0.5 μmol/L of Se-Car, but significantly higher LDH release was observed at 2–5 μmol/L of Na2SeO3 and 3–5 μmol/L of Se-Car, and the response occurred in a dose-dependent manner. The intracellular content of reduced glutathione in all hepatocytes treated with Se was significantly lower than that of controls. Significant increases in GPx1 mRNA were obtained in all hepatocytes treated with Se, with maximal effects at 3 μmol/L of Se-Met, 1.5 μmol/L of Na2SeO3 and 2 μmol/L of Se-Car, respectively. Furthermore, 3 μmol/L of Se from Se-Met resulted in peak levels of GPx1 mRNA. After reaching a maximal level, higher Se supplementation led to a reduction of GPx1 mRNA. The activity of GPx1 showed similar patterns but of lower magnitude. We conclude that (a) the regulation of mRNA level and activity of GPx1 in primary cultured bovine hepatocytes by different forms of Se varies and (b) the optimal doses of Se to support the full expression of GPx1 in bovine hepatocytes when supplied as Se-Met, Na2SeO3 and Se-Car are 3, 1.5 and 2 μmol/L, respectively.</description><dc:title>Regulation of cellular glutathione peroxidase by different forms and concentrations of selenium in primary cultured bovine hepatocytes</dc:title><dc:creator>Xianshi Wu, Kehe Huang, Chengwu Wei, Fu Chen, Cuiling Pan</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-03-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-03-09</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>153</prism:startingPage><prism:endingPage>161</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286308002696/abstract?rss=yes"><title>Zinc retention differs between primary and transformed cells in response to zinc deprivation</title><link>http://www.jnutbio.com/article/PIIS0955286308002696/abstract?rss=yes</link><description>Abstract: Previous studies in our laboratory have demonstrated that reducing the availability of zinc with the extracellular metal chelator DTPA (diethylenetriaminepentaacetate) enhances, rather than inhibits, the thyroid hormone induction of growth hormone mRNA in GH3 rat anterior pituitary tumor cells. To understand the actions of the chelator on cellular zinc status, we observed the effects of DTPA on 65Zn uptake and retention. DTPA reduced the uptake of 65Zn by GH3 cells from the medium, but when GH3 cells were prelabeled with 65Zn, it resulted in greater retention of the isotope. In primary hepatocytes, DTPA both reduced the uptake of 65Zn from the medium and increased efflux from prelabeled cells. To investigate this difference, we studied the effects of DTPA on radioactive zinc flux in the H4IIE (rat hepatoma), MCF-7 (human breast cancer) and Hs578Bst (nontransformed human mammary) cell lines and in rat primary anterior pituitary cells. DTPA reduced the uptake of 65Zn in all cell lines examined. DTPA increased the retention of 65Zn in prelabeled H4IIE, MCF-7 and Hs578Bst cells but reduced it in primary pituitary cells. Time course experiments showed that 65Zn efflux is shut down rapidly by DTPA in transformed cells, whereas the chelator causes greater efflux from primary hepatocytes over the first 6 h. Experiments with 14C-labeled DTPA confirmed that this chelator does not cross cell membranes, showing that it operates entirely within the medium. Expression of ZnT-1, the efflux transporter, was not affected by DTPA in H4IIE cells. Thus, zinc deprivation enhanced zinc retention in established cell lines but increased efflux from primary cells, perhaps reflecting differing requirements for this mineral.</description><dc:title>Zinc retention differs between primary and transformed cells in response to zinc deprivation</dc:title><dc:creator>Amrita Dutta, Matthew Schaller, Aime T. Franco, Kavitha Sankavaram, Bruce J. Grattan, Hedley C. Freake</dc:creator><dc:identifier>10.1016/j.jnutbio.2008.12.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 21, 2 (2010)</dc:source><dc:date>2009-03-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-03-09</prism:publicationDate><prism:volume>21</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0955-2863(09)X0013-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>162</prism:startingPage><prism:endingPage>170</prism:endingPage></item></rdf:RDF>